{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-021361","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.535776+00:00","generated_at":"2026-05-18T18:01:57.475288+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Reviva prices $10M public offering of 20M shares and warrants at $0.50 per unit","bullets":["Offering comprises 20M shares, 20M Series C warrants (5-year, $0.50 exercise), and 20M Series D warrants (12-month, $0.50 exercise).","Gross proceeds of $10M; net proceeds expected ~$9.0M after fees.","Net proceeds to fund R&D, working capital, and general corporate purposes.","Closing expected June 27, 2025; 60-day lock-up on share issuance and one-year variable rate transaction restriction.","A.G.P./Alliance Global Partners serving as sole placement agent with 7.0% cash fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-021361","json":"https://secwatch.observer/filing/0001437749-25-021361.json","markdown":"https://secwatch.observer/filing/0001437749-25-021361.md","text":"https://secwatch.observer/filing/0001437749-25-021361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/0001437749-25-021361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/rvph20250626_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T18:01:57.475288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}